TGFBR3 and cancer: In gastric cancer, [28] Fang et al., 2024, reported that SULF1, produced by cancer-associated fibroblasts (CAFs), facilitated metastasis and resistance to cisplatin treatment via TGFB1 activation of TGFBR3-mediated signaling.